Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound. Our technology empowers clinicians to make precise, efficient, and accurate assessments, drawing from the largest known heart disease dataset in echocardiography. We target challenging cardiac diseases, starting with HFpEF, to support timely diagnosis and early intervention. In collaboration with the Mayo Clinic, Johnson & Johnson, and Pfizer, we are continuously developing innovative diagnostic tools aimed at halting the progression of heart failure. Learn more: https://www.ultromics.com/. Follow Ultromics on social media for the latest news, X: https://x.com/ultromics, LinkedIn: https://www.linkedin.com/company/ultromics/.
Looking for a particular Ultromics employee's phone or email?
The Ultromics annual revenue was $21 million in 2026.
Amir Hasan is the Chief Operating Officer (COO) of Ultromics.
64 people are employed at Ultromics.
The NAICS codes for Ultromics are [54, 541, 541511, 518, 51, 54151, 5415].
The SIC codes for Ultromics are [737, 73].